[home]
[thesaurus]
Click Here to return To Results
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease
AJNR 31:347-354, Walhovd, K.B.,et al, 2010
See this aricle in Pubmed
Article Abstract
All biomarkers were sensitive to the diagnostic group. Combining MR imaging morphometry and CSF biomarkers improved diagnostic classification (controls versus AD). MR imaging morphometry and PET were largely overlapping in value of discrimination. Baseline MR imaging and PET measures were more predictive of clinical change in MCI than were CSF measures.
Related Tags
(click to filter results - removes previous filter)
Alzheimer's disease
biologic markers
CAT scan,emission
CAT scan,emission,abnormal
cerebrospinal fluid,biochemical markers of CNS disease
hippocampal atrophy
hippocampus
MRI,abnormal
MRI,volumetry
MRI,voxel-based morphometry
neurologic disease,diagnoses of
prognosis
tau protein
Click Here to return To Results